Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Apr 21;97(2):489-500.
doi: 10.1227/neu.0000000000003453.

Is FLAIRectomy Directly Correlated with Prolonged Survival in Glioblastoma? A Prospective National Multicenter Study on Correlation Between Extent of Tumor Resection and Clinical Outcome

Francesco Certo  1   2 , Alessandro Pluchino  3 , Andrea Maugeri  4 , Guglielmo Ferranti  3 , Giuseppe Broggi  5 , Rosario Caltabiano  5 , Antonio Melcarne  6 , Roberta Rudà  7 , Giuseppe M Della Pepa  8 , Giuseppe La Rocca  7   9 , Giovanni Sabatino  7   9 , Massimiliano Visocchi  8 , Andrea Rapisarda  3   10 , Antonella Agodi  4 , Gaetano Magro  5 , Diego Garbossa  6 , Alessandro Olivi  8 , Vincenzo Albanese  1 , Giuseppe M V Barbagallo  1   2
Affiliations
Multicenter Study

Is FLAIRectomy Directly Correlated with Prolonged Survival in Glioblastoma? A Prospective National Multicenter Study on Correlation Between Extent of Tumor Resection and Clinical Outcome

Francesco Certo et al. Neurosurgery. .

Abstract

Background and objectives: Several articles have demonstrated a positive correlation between glioblastoma supramarginal resection, based on MRI fluid-attenuated inversion-recovery (FLAIR) sequences (ie, FLAIRectomy), and prolonged survival. This study analyses the efficacy, safety, and reliability of FLAIRectomy in a multicentric cohort of patients, correlating the extent of FLAIR resection (EOFR) with clinical outcome and survival.

Methods: One hundred fifty glioblastoma or grade IV astrocytoma patients (82 men), with a mean age of 58.2 years (range 36-82 years), from 3 neurosurgical centers were included. In all cases, supramarginal resection was deemed feasible preoperatively; multicentric neoplasms or tumors with enhancing nodule involving eloquent areas were excluded. Analysis of EOFR was based on comparison between preoperative and postoperative 3-dimensional FLAIR images. EOFR was compared with extent of tumor resection (EOTR) based on gadolinium-enhanced T1 sequences; theses data were also statistically correlated with survival parameters as well as with clinical and biomolecular data.

Results: EOFR rate was 78.8% in the entire cohort, whereas EOTR based on T1 sequences was 98.3%. Mean progression free survival (PFS) and overall survival (OS) were 16.33 and 28.4 months, respectively. Adjusted Cox-regression models showed that a higher EOTR based on T1 sequences and EOFR were both associated with improved OS in individuals with either isocytrate dehydrogenase-1 wild-type or isocytrate dehydrogenase-1 mutated tumors. After adjustment, only the EOFR retained a statistically significant association with OS. Specifically, the risk of mortality decreased by 6.8% and 12.1% with each one-unit increase in EOFR, respectively. Further analysis based on artificial intelligence demonstrated that the cluster of patients with higher values of PFS and OS received greater rate of FLAIRectomy.

Conclusion: This multicenter study demonstrates that EOFR is a more reliable predictor of PFS and OS than extent of resection based on gadolinium-enhanced T1 sequences, if supramarginal resection is performed according to specific preoperative planning. 3-dimensional FLAIR navigation-guided resection may represent the optimal strategy to achieve a real FLAIRectomy.

Keywords: Extent of resection; FLAIR; FLAIRectomy; Glioblastoma; Supramarginal resection; Survival.

PubMed Disclaimer

References

    1. Chinot OL, Wick W, Mason W, et al. Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma. N Engl J Med. 2014;370(8):709-722.
    1. Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol. 2015;17(Suppl 4):iv1-iv62.
    1. Altieri R, Broggi G, Certo F, et al. Anatomical distribution of cancer stem cells between enhancing nodule and FLAIR hyperintensity in supratentorial glioblastoma: time to recalibrate the surgical target? Neurosurg Rev. 2022;45(6):3709-3716.
    1. Altieri R, Barbagallo D, Certo F, et al. Peritumoral microenvironment in high-grade gliomas: from FLAIRectomy to microglia-glioma cross-talk. Brain Sci. 2021;11(2):200.
    1. Barbagallo GMV, Paratore S, Caltabiano R, et al. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Neurosurg Focus. 2014;37(6):e4.

Publication types

LinkOut - more resources